Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study

@article{Beusterien2010PopulationPV,
  title={Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study},
  author={K. Beusterien and J. Davies and M. Leach and D. Meiklejohn and J. Grinspan and A. O'Toole and Steve Bramham-Jones},
  journal={Health and Quality of Life Outcomes},
  year={2010},
  volume={8},
  pages={50 - 50}
}
BackgroundGiven that treatments for chronic lymphocytic leukaemia (CLL) are palliative rather than curative, evaluating the patient-perceived impacts of therapy is critical. To date, no utility (preference) studies from the general public or patient perspective have been conducted in CLL. The objective of this study was to measure preferences for health states associated with CLL treatment.MethodsThis was a cross-sectional study of 89 members of the general population in the UK (England and… Expand
69 Citations
Population preference values for health states in relapsed or refractory B-precursor acute lymphoblastic leukemia in the United Kingdom
  • 7
  • Highly Influenced
Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States
  • 7
A Systematic Review of Utility Values for Chemotherapy-Related Adverse Events
  • 39
  • Highly Influenced
  • PDF
Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States.
  • Q. Chen, N. Jain, +6 authors J. Chhatwal
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2017
  • 85
  • PDF
Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada
  • 7
  • Highly Influenced
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
Health state utilities for metastatic breast cancer
  • 197
  • PDF
A multinational study of health state preference values associated with chronic myelogenous leukemia.
  • 29
Patients’ experience of chronic lymphocytic leukaemia: baseline health‐related quality of life results from the LRF CLL4 trial
  • 46
Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.
  • 46
Economic Evaluation of Third-Line Treatment with Alemtuzumab for Chronic Lymphocytic Leukaemia
  • 11
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients
  • 106
  • PDF
Chronic Lymphocytic Leukemia: Economic Burden and Quality of Life: Literature Review
  • 42
Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial
  • 44
  • PDF
The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons.
  • A. Levy, K. Kowdley, +5 authors A. Briggs
  • Medicine
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
  • 2008
  • 128
Societal preference values for advanced melanoma health states in the United Kingdom and Australia
  • 59
  • PDF
...
1
2
3
4
5
...